Dow Up 0.76% Nasdaq Up 0.69%

Theravance Inc. (THRX)

-NasdaqGS
17.08 Down 0.09(0.52%) Oct 24, 4:00PM EDT
|After Hours : 17.08 0.00 (0.00%) Oct 24, 4:52PM EDT
Prev Close:17.17
Open:17.17
Bid:16.20 x 200
Ask:N/A
1y Target Est:28.00
Beta:1.12
Next Earnings Date:30-Oct-14THRX Earnings announcement
Day's Range:16.80 - 17.29
52wk Range:15.76 - 32.89
Volume:624,306
Avg Vol (3m):809,549
Market Cap:1.96B
P/E (ttm):N/A
EPS (ttm):-2.09
Div & Yield:0.50 (2.90%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
THRXDown 0.52%1.96B
AZNUp 1.11%88.56B
CBSTDown 2.06%5.39B
PFEUp 1.78%184.58B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):870.72
Ex-Dividend Date:26-Aug-14

Analysts

Annual EPS Est (Dec-14) :-1.35
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback